Diflucortolone 21-Valerate(CAS: 59198-70-8)

Diflucortolone 21-Valerate (CAS: 59198-70-8) falls under several regulatory guidelines, including GHS classification for its physical and health hazards, REACH regulations for its use in the EU, and FDA/EPA requirements for its manufacture and distribution. Compliance with these regulations ensures safe handling, storage, and disposal of the compound.

Alternative reagents such as betamethasone valerate or triamcinolone acetonide valerate can be used as substitutes in synthesis processes for Diflucortolone 21-Valerate (CAS: 59198-70-8). These alternatives offer similar anti-inflammatory effects and can be chosen based on specific chemical and biological requirements.

The market trend for Diflucortolone 21-Valerate (CAS: 59198-70-8) reflects a growing interest in topical corticosteroids for skin diseases. Research is focusing on optimizing its efficacy and safety, as well as exploring its potential in other therapeutic areas. Market demand is driven by increasing patient needs and advancements in dermatological treatments.

Waste containing Diflucortolone 21-Valerate (CAS: 59198-70-8) should be collected and disposed of in accordance with local hazardous waste regulations. Proper waste management includes the use of appropriate collection containers, ensuring no cross-contamination, and following safe incineration or professional waste disposal methods to prevent environmental pollution and ensure worker safety.